Cutaneous Leishmaniasis Unknown Status Phase Trials for Sodium stibogluconate (DB05630)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Unknown StatusNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02281669Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients